Compounds > chitosan
Page last updated: 2024-08-25

chitosan and demethoxycurcumin

chitosan has been researched along with demethoxycurcumin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, HY; Liu, DM; Wang, YJ; Wu, CH1
Devasena, T; Francis, AP; Subramanian, SB1
Chiou, SH; Huang, WT; Larsson, M; Lin, HY; Liu, DM; Wang, YJ1
Chiou, GY; Huang, WT; Larsson, M; Lee, YC; Liu, DM1
Chen, YY; Huang, WT; Hung, CC; Lan, SJ; Lin, HY; Lin, YJ; Liu, DM; Sheu, MJ; Tu, YC1

Other Studies

5 other study(ies) available for chitosan and demethoxycurcumin

ArticleYear
Forming of demethoxycurcumin nanocrystallite-chitosan nanocarrier for controlled low dose cellular release for inhibition of the migration of vascular smooth muscle cells.
    Molecular pharmaceutics, 2012, Aug-06, Volume: 9, Issue:8

    Topics: Cell Line; Cell Movement; Cell Survival; Chitosan; Curcumin; Diarylheptanoids; Drug Carriers; Flow Cytometry; Humans; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nanoparticles

2012
Chitosan-starch nanocomposite particles as a drug carrier for the delivery of bis-desmethoxy curcumin analog.
    Carbohydrate polymers, 2014, Dec-19, Volume: 114

    Topics: Animals; Cell Survival; Chitosan; Chlorocebus aethiops; Curcumin; Diarylheptanoids; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Humans; MCF-7 Cells; Nanocomposites; Nanoparticles; Starch; Vero Cells

2014
Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation.
    Molecular pharmaceutics, 2015, Apr-06, Volume: 12, Issue:4

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Curcumin; Cytoplasm; Diarylheptanoids; Drug Carriers; Drug Delivery Systems; ErbB Receptors; Humans; Inhibitory Concentration 50; Light; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanomedicine; Nanoparticles; Neoplasm Transplantation; Scattering, Radiation

2015
Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2016, Volume: 109

    Topics: A549 Cells; AC133 Antigen; Antineoplastic Agents; Biomarkers; Chitosan; Cisplatin; Colloids; Curcumin; Diarylheptanoids; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Humans; Kinetics; Lung Neoplasms; Nanoparticles; Neoplastic Stem Cells; Photoelectron Spectroscopy; Spectroscopy, Fourier Transform Infrared

2016
Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer.
    Molecules (Basel, Switzerland), 2018, Dec-05, Volume: 23, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chitosan; Cisplatin; Curcumin; Diarylheptanoids; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Microscopy, Confocal; Nanoparticles; Proto-Oncogene Proteins c-akt

2018